Assessment of coronary reperfusion after thrombolysis with a model combining myoglobin, creatine Kinase-MB, and clinical variables

被引:31
|
作者
Christenson, RH
Ohman, EM
Topol, EJ
Peck, S
Newby, LK
Duh, SH
Kereiakes, DJ
Worley, SJ
Alosozana, GL
Wall, TC
Califf, RM
机构
[1] DUKE UNIV, MED CTR, DEPT MED, DIV CARDIOL, DURHAM, NC 27710 USA
[2] CLEVELAND CLIN FDN, DEPT CARDIOL, CLEVELAND, OH 44195 USA
[3] CHRIST HOSP, CINCINNATI, OH 45219 USA
[4] LANCASTER GEN HOSP, LANCASTER, PA USA
[5] MOSES CONE HOSP, GREENSBORO, NC USA
关键词
creatine kinase; myoglobin; reperfusion; thrombolysis;
D O I
10.1161/01.CIR.96.6.1776
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Several biochemical markers have been investigated for the noninvasive assessment of reperfusion after myocardial infarction. Because myoglobin is released very soon after myocardial injury and clears rapidly after reperfusion, it may prove to be an excellent marker of occlusion and reperfusion. Methods and Results We examined the relation between various myoglobin measures and Thrombolysis In Myocardial Infarction (TIMI) flow grade in 96 patients enrolled in a study of front-loaded thrombolysis who underwent 90-minute angiography. We also combined myoglobin measures with models that include clinical and creatine kinase-MB variables. The myoglobin level measured within 10 minutes of acute angiography showed the best overall performance and was used for later analyses. Of the clinical variables examined, only time from symptom onset to thrombolysis and chest pain grade at angiography discriminated among TIMI flow grades. Combining the 90-minute myoglobin level and these clinical variables showed a significant difference (P<.0001) between both TIMI 3 versus TIMI 0 through 2 and TIMI 2 or 3 versus TIMI 0 or 1 flow. When the 90-minute myoglobin level was added to an established predictive model containing clinical variables and creatine kinase-MB measures, its contribution remained significant (P=.044). The area under the receiver operator characteristic curve for this combined model was .88. Conclusions A single myoglobin measurement obtained 90 minutes after the start of thrombolysis, combined with select clinical variables and creatine kinase-MB levels, enhances the noninvasive prediction of reperfusion after myocardial infarction.
引用
收藏
页码:1776 / 1782
页数:7
相关论文
共 24 条
  • [1] ANALYSIS OF CREATINE-KINASE, CK-MB, MYOGLOBIN, AND TROPONIN-T TIME-ACTIVITY CURVES FOR EARLY ASSESSMENT OF CORONARY-ARTERY REPERFUSION AFTER INTRAVENOUS THROMBOLYSIS
    ZABEL, M
    HOHNLOSER, SH
    KOSTER, W
    PRINZ, M
    KASPER, W
    JUST, H
    CIRCULATION, 1993, 87 (05) : 1542 - 1550
  • [2] Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions
    Abdelmeguid, AE
    Topol, EJ
    Whitlow, PL
    Sapp, SK
    Ellis, SG
    CIRCULATION, 1996, 94 (07) : 1528 - 1536
  • [3] Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation
    Ricciardi, MJ
    Wu, E
    Davidson, CJ
    Choi, KM
    Klocke, FJ
    Bonow, RO
    Judd, RM
    Kim, RJ
    CIRCULATION, 2001, 103 (23) : 2780 - 2783
  • [4] Comparison of cardiac troponin I, creatine kinase-MB, and myoglobin for detection of acute ischemic myocardial injury in a swine model
    Feng, YJ
    Chen, CG
    Fallon, JT
    Lai, TJ
    Chen, LL
    Knibbs, DR
    Waters, DD
    Wu, AHB
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1998, 110 (01) : 70 - 77
  • [5] Assessment of a creatine kinase-MB/myoglobin kit in the prehospital setting in patients presenting with acute nontraumatic chest pain: The "Shahal" experience
    Roth, A
    Malov, N
    Bloch, Y
    Golovner, M
    Slesarenko, Y
    Naveh, R
    Kaplinsky, E
    Laniado, S
    CRITICAL CARE MEDICINE, 1999, 27 (06) : 1085 - 1089
  • [6] Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes
    Roe, MT
    Mahaffey, KW
    Kilaru, R
    Alexander, JH
    Akkerhuis, KM
    Simoons, ML
    Harrington, RA
    Tardiff, BE
    Granger, CB
    Ohman, EM
    Moliterno, DJ
    Lincoff, AM
    Armstrong, PW
    Van de Werf, F
    Califf, RM
    Topol, EJ
    EUROPEAN HEART JOURNAL, 2004, 25 (04) : 313 - 321
  • [7] DETECTION OF CORONARY-ARTERY PATENCY AFTER THROMBOLYTIC THERAPY OF ACUTE MYOCARDIAL-INFARCTION USING CREATINE KINASE-MB SUBFORMS
    PULEO, PR
    CORONARY ARTERY DISEASE, 1992, 3 (06) : 468 - 474
  • [8] Periprocedural creatine kinase-MB elevations: Long-term impact and clinical implications
    Adgey, AAJ
    Mathew, TP
    Harbinson, MT
    CLINICAL CARDIOLOGY, 1999, 22 (04) : 257 - 265
  • [9] Weak diagnostic performance of troponin, creatine kinase and creatine kinase-MB to diagnose or exclude myocardial infarction after successful resuscitation
    Kruse, Jan M.
    Enghard, Philipp
    Schroeder, Tim
    Hasper, Dietrich
    Kuehnle, York
    Joerres, Achim
    Storm, Christian
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 173 (02) : 216 - 221
  • [10] Multicenter study of creatine kinase-MB use: Effect on chest pain clinical decision making
    Hedges, JR
    Gibler, WB
    Young, GP
    Hoekstra, JW
    Slovis, C
    Aghababian, R
    Smith, M
    Rubison, M
    ACADEMIC EMERGENCY MEDICINE, 1996, 3 (01) : 7 - 15